Treatment patterns, complications, and disease relapse in a real-world population of patients with moderate-to-severe ulcerative colitis initiating immunomodulator therapy
Journal
Inflammatory bowel diseases
Journal Volume
20
Journal Issue
8
Pages
1361
Date Issued
2014-08
Author(s)
Abstract
Immunomodulator (IM) treatments in ulcerative colitis (UC) are not curative and carry increased risk of complications, sometimes leading to therapy changes, reduced treatment benefits, and eventual relapse. We assessed patterns of IM utilization and therapy changes, complications, and disease relapse in a real-world population of patients with moderate-to-severe UC.
Subjects
Complications | Immunomodulators | Relapse | Treatment patterns | Ulcerative colitis
Type
journal article